Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone

A DNA-Based Candidate HIV Vaccine Delivered viaIn VivoElectroporation Induces CD4 Responses toward the α4β7-Binding V2 Loop of HIV gp120 in Healthy Volunteers

(2012) Jakub Kopycinski et al.   Clinical and Vaccine Immunology

Optimization of Electroporation-Enhanced Intradermal Delivery of DNA Vaccine Using a Minimally Invasive Surface Device

(2012) Feng Lin et al.   Human Gene Therapy Methods

New Japanese encephalitis vaccines: alternatives to production in mouse brain

(2011) Scott B Halstead et al.   Expert Review of Vaccines

Development of sanofi pasteur tetravalent dengue vaccine

(2011) Bruno Guy et al.   Human vaccines & immunotherapeutics

In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers

(2011) Sandhya Vasan et al.   PLoS One

IMOJEV®: a Yellow fever virus-based novel Japanese encephalitis vaccine

(2010) Mohan Babu Appaiahgari et al.   Expert Review of Vaccines

Plasmid DNA vaccination using skin electroporation promotes poly-functional CD4 T-cell responses

(2010) Andreas Bråve et al.   IMMUNOLOGY AND CELL BIOLOGY

An RNA Pseudoknot Is Required for Production of Yellow Fever Virus Subgenomic RNA by the Host Nuclease XRN1

(2010) P. A. G. C. Silva et al.   JOURNAL OF VIROLOGY

Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii

(2010) Cristina T. Stoyanov et al.   VACCINE

Introduction to DNA vaccines – Las Vegas

(2010) David B. Weiner et al.   VACCINE

Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development

(2010) David Franco et al.   VACCINE

Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation

(2010) Andreas Bråve et al.   VACCINE

Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs

(2010) Xiaohong Jiang et al.   VACCINE

Yellow fever vaccine—how does it work and why do rare cases of serious adverse events take place?

(2009) Alan DT Barrett et al.   CURRENT OPINION IN IMMUNOLOGY

A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A

(2009) David F. Gardiner et al.   VACCINE

A Mouse Model for Studying Viscerotropic Disease Caused by Yellow Fever Virus Infection

(2009) Kathryn C. Meier et al.   PLoS Pathogens

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

(2008) Denis Gaucher et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

(2008) Troy D Querec et al.   NATURE IMMUNOLOGY

DNA vaccines: ready for prime time?

(2008) Michele A. Kutzler et al.   NATURE REVIEWS GENETICS

Comprehensive analysis of T cell epitope discovery strategies using 17DD yellow fever virus structural proteins and BALB/c (H2d) mice model

(2008) Milton Maciel et al.   VIROLOGY